Vascular effects of RWJ-676070, a selective combined V1a/V2 vasopressin receptor antagonist

Clin Pharmacol Ther. 2009 Feb;85(2):145-8. doi: 10.1038/clpt.2008.217. Epub 2008 Nov 5.
No abstract available

Publication types

  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antidiuretic Hormone Receptor Antagonists*
  • Benzazepines / pharmacology*
  • Cross-Over Studies
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Humans
  • Male
  • Receptors, Vasopressin / physiology
  • Regional Blood Flow / drug effects*
  • Regional Blood Flow / physiology
  • Skin / blood supply*
  • Skin / drug effects*
  • Spiro Compounds / pharmacology*
  • Young Adult

Substances

  • Antidiuretic Hormone Receptor Antagonists
  • Benzazepines
  • RWJ-676070
  • Receptors, Vasopressin
  • Spiro Compounds